• A-1210477: Mapping MCL-1 Apoptotic Dependency

  2026-08-19

  A-1210477 is an MCL-1 inhibitor for resolving how cancer cells depend on mitochondrial apoptosis. This guide connects binding, BAX/BAK competence, orthogonal assay design, and translational interpretation without overstating in vivo potential.

• Batimastat (BB-94): From MMPs to Synapses

  2026-08-18

  A translational framework for using Batimastat (BB-94) to connect matrix metalloproteinase activity with tumor invasion, angiogenesis, and spatially controlled BDNF processing at developing neuromuscular synapses.

• GLP-1 (9-36) amide for Receptor Studies

  2026-08-18

  GLP-1 (9-36) amide supports controlled blockade experiments that separate GLP-1 receptor activity from ligand cross-reactivity. This guide translates cAMP assay findings into practical workflows for GPCR signaling, metabolic regulation, and type 2 diabetes research.

• LC–MS/MS Maps GS-441524 Prodrug Conversion

  2026-08-17

  A January 2026 Microchemical Journal study established an LC–MS/MS workflow for tracking conversion of the novel GS-441524 prodrug NGP-1 to GS-441524 across gastric fluid, blood, liver microsomes, and a rat liver-injury model. Its findings support a sequential absorption and biotransformation model that can inform oral prodrug design and GS-441524 pharmacokinetics studies.

• BEND Lipids Improve mRNA and CRISPR Delivery

  2026-08-17

  The reference study introduces branched endosomal disruptor lipids as an ionizable-lipid design strategy for improving LNP delivery of mRNA and CRISPR-Cas9 ribonucleoproteins. Its comparative experiments connect terminal lipid branching with enhanced endosomal penetration, hepatic gene-editing performance, and T-cell transfection, while also clarifying the limits of transferring results across cargos and cell types.

• Palonosetron: Evidence for CINV Prevention

  2026-08-16

  The review by Ruhlmann and Herrstedt examines how palonosetron’s high-affinity, allosteric 5-HT3 receptor binding and prolonged half-life may translate into durable control of chemotherapy-induced nausea and vomiting. Its central practical contribution is a balanced comparison of palonosetron with earlier 5-HT3 antagonists, while emphasizing separate assessment of acute emesis, delayed symptoms, nausea, and combination antiemetic therapy.

• Poly-Arginine MIP Sensor for Dimetridazole Detection

  2026-08-15

  The 2020 Analytica Chimica Acta study developed a poly-arginine molecularly imprinted polymer sensor for selective, ultra-trace detection of Dimetridazole (1,2-Dimethyl-5-nitroimidazole). Its GCE/P-Arg@MIP electrode combined electrochemical deposition with differential pulse voltammetry and achieved a 0.1 nM detection limit while supporting analysis in egg, milk, and honey.

• Intravesical p21 mRNA-LNP Therapy in Bladder Cancer

  2026-08-14

  This FASEB Journal study develops chemically modified p21 mRNA encapsulated in lipid nanoparticles for localized intravesical treatment of bladder cancer. The work links tumor-suppressor restoration to cell-cycle inhibition, DNA-damage signaling, apoptosis, bladder-localized expression, and tumor suppression in an orthotopic mouse model.

• Fluoxetine HCl: Serotonergic Mechanisms & Research

  2026-08-14

  Fluoxetine HCl is a selective serotonin reuptake inhibitor used to examine serotonin transporter activity, 5-HT2C receptor signaling, neurogenesis, and behavior. Its research value depends on separating acute receptor assays from chronic plasticity models and developmental exposure paradigms.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP) for Cell Assays

  2026-08-13

  Learn how SKU R1011, EZ Cap™ Cy5 EGFP mRNA (5-moUTP), separates mRNA uptake from functional translation in viability, proliferation, cytotoxicity, and macrophage delivery studies. This scenario-based guide covers assay design, handling, data interpretation, and practical product selection using product specifications and published nanoparticle evidence.

• FITC-Concanavalin A (ConA) Workflow Guide

  2026-08-13

  FITC-Concanavalin A is a fluorescent lectin conjugate for detecting accessible α-D-glucose and α-D-mannose residues in cell-surface and tissue samples. It is intended for carbohydrate-focused immunofluorescence staining and flow cytometry workflows, not for non-carbohydrate targets or use outside the stated storage and stability conditions.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-08-12

  FITC-Concanavalin A (ConA) Conjugate is a fluorescent lectin probe for visualizing α-D-glucose and α-D-mannose residues on cell surfaces, tissue sections, and other glycoprotein-rich samples. It is suited to immunofluorescence, flow cytometry, and glycobiology workflows, but should not be interpreted as a universal glycan stain or used outside validated carbohydrate-binding assays.

• ECL Chemiluminescent Substrate Detection Kit Workflow

  2026-08-12

  Apply hypersensitive HRP chemiluminescence to low-abundance immunoblots, including mitochondrial and ER-remodeling studies in trigeminal neuron–glia models. This workflow combines extended signal availability, low background, and practical exposure strategies for reliable protein detection on nitrocellulose or PVDF membranes.

• Dovitinib (TKI-258) Cancer Research Workflows

  2026-08-11

  Build reproducible RTK-inhibition experiments with Dovitinib across hematologic and solid-tumor models, while separating pathway suppression from nonspecific toxicity. This workflow connects dose-response testing, ERK/STAT readouts, apoptosis assays, and immune-signature profiling for more informative translational studies.

• BIRC2 and BIRC3 Regulation in Pulmonary Epithelium

  2026-08-11

  Thorne et al. show that inflammatory cytokines and glucocorticoids regulate BIRC2 and BIRC3 differently in pulmonary epithelial models. The work identifies BIRC3 as a strongly inducible, potentially protective response, while relatively stable BIRC2 may support rapid signaling functions.

8101 records 3/541 page Previous Next 12345 下5页 Last page